Avoro Capital Advisors LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1633313
NEW YORK, NY
Position in MDGL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$951,763,208
-$100,816,342 QoQ
Shares Held
1,818,181
+0.6% QoQ
Ownership
7.89%
of shares outstanding
% of Portfolio
9.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Avoro Capital Advisors LLC holds $8,549,473,651 across 28 Biotechnology names. MDGL ranks #2 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,062,500 | $1,157,945,625 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
This page
|
1,818,181 | $951,763,208 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $746,257,548 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $730,250,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,699,999 | $670,889,937 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $622,571,677 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
12,222,222 | $491,699,991 | |
| 8 | CNTA |
Centessa Pharmaceuticals plc
|
11,430,455 | $454,017,672 |
All Filings in MDGL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $951,763,208 | 1,818,181 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,052,579,550 | 1,807,500 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $840,723,780 | 1,833,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $567,450,000 | 1,875,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $669,820,593 | 2,022,222 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $626,088,530 | 2,029,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $430,594,380 | 2,029,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $575,884,288 | 2,055,555 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $519,244,325 | 1,944,444 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $437,050,905 | 1,888,888 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $227,092,200 | 1,555,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $349,999,881 | 1,515,151 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $403,766,505 | 1,666,666 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $481,815,000 | 1,660,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $99,759,650 | 1,535,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $109,875,300 | 1,535,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $139,821,000 | 1,425,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $120,754,500 | 1,425,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $113,700,750 | 1,425,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $138,809,250 | 1,425,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $166,682,250 | 1,425,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $136,183,250 | 1,225,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $105,669,700 | 890,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $39,637,500 | 350,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $23,299,240 | 349,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||